Activation of NPY-Y2 receptors ameliorates disease pathology in the R6/2 mouse and PC12 cell models of Huntington's disease
- 1 April 2018
- journal article
- research article
- Published by Elsevier in Experimental Neurology
- Vol. 302, 112-128
Abstract
No abstract availableKeywords
Funding Information
- Ruhr-University Bochum (F823R-14)
This publication has 98 references indexed in Scilit:
- Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive ImpairmentArchives of Neurology, 2012
- TrkB receptor controls striatal formation by regulating the number of newborn striatal neuronsProceedings of the National Academy of Sciences, 2011
- Neuropeptide Y Modulation of Interleukin-1β (IL-1β)-induced Nitric Oxide Production in MicrogliaJournal of Biological Chemistry, 2010
- Neuropeptide Y Has a Protective Role during Murine Retrovirus-Induced Neurological DiseaseJournal of Virology, 2010
- Mutant Huntingtin Alters Cell Fate in Response to Microtubule Depolymerization via the GEF-H1-RhoA-ERK PathwayJournal of Biological Chemistry, 2010
- Impaired TrkB-mediated ERK1/2 Activation in Huntington Disease Knock-in Striatal Cells Involves Reduced p52/p46 Shc ExpressionJournal of Biological Chemistry, 2010
- Selective and Brain Penetrant Neuropeptide Y Y2 Receptor Antagonists Discovered by Whole-Cell High-Throughput ScreeningMolecular Pharmacology, 2010
- A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's diseaseJournal of Experimental Medicine, 2008
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008
- Peptidergic influences on proliferation, migration, and placement of neural progenitors in the adult mouse forebrainProceedings of the National Academy of Sciences, 2008